Published in Antimicrob Agents Chemother on July 01, 1995
DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev (1997) 9.69
High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA. Antimicrob Agents Chemother (1996) 4.04
Molecular detection of antimicrobial resistance. Clin Microbiol Rev (2001) 2.31
Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC. Antimicrob Agents Chemother (1998) 1.91
Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrob Agents Chemother (1997) 1.58
Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus. Antimicrob Agents Chemother (1997) 1.55
Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother (1996) 1.42
Detection of grlA and gyrA mutations in 344 Staphylococcus aureus strains. Antimicrob Agents Chemother (1998) 1.36
Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus. Antimicrob Agents Chemother (1998) 1.31
Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus. Antimicrob Agents Chemother (1999) 1.29
Amino acid variation in the GyrA subunit of bacteria potentially associated with natural resistance to fluoroquinolone antibiotics. Antimicrob Agents Chemother (1997) 1.06
Alterations in GyrA and ParC associated with fluoroquinolone resistance in Enterococcus faecium. Antimicrob Agents Chemother (1999) 1.03
Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones. Antimicrob Agents Chemother (1999) 0.99
Topoisomerase mutations in trovafloxacin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1998) 0.88
Activity of gatifloxacin in an in vitro pharmacokinetic-pharmacodynamic model against Staphylococcus aureus strains either susceptible to ciprofloxacin or exhibiting various levels and mechanisms of ciprofloxacin resistance. Antimicrob Agents Chemother (2006) 0.86
Sequence of quinolone resistance-determining region of gyrA gene for clinical isolates and for an in vitro-selected quinolone-resistant strain of Coxiella burnetii. Antimicrob Agents Chemother (1996) 0.85
Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol (1978) 29.77
Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A (1989) 18.26
DNA topoisomerases. Annu Rev Biochem (1985) 13.01
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother (1990) 11.71
Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J Bacteriol (1990) 7.61
DNA gyrase: structure and function. Crit Rev Biochem Mol Biol (1991) 5.25
DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli. J Bacteriol (1990) 5.13
Mapping the active site tyrosine of Escherichia coli DNA gyrase. J Biol Chem (1987) 4.68
Fluoroquinolone antimicrobial agents. N Engl J Med (1991) 4.65
PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl (1991) 4.58
Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital. Antimicrob Agents Chemother (1989) 4.04
Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus. Antimicrob Agents Chemother (1994) 3.96
Nucleotide sequence of the Staphylococcus aureus gyrB-gyrA locus encoding the DNA gyrase A and B proteins. J Bacteriol (1992) 3.95
A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus. J Bacteriol (1991) 3.70
Detection of gyrA gene mutations associated with ciprofloxacin resistance in methicillin-resistant Staphylococcus aureus: analysis by polymerase chain reaction and automated direct DNA sequencing. Antimicrob Agents Chemother (1992) 3.36
Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug--DNA binding model. Biochemistry (1989) 3.09
Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones. J Clin Microbiol (1989) 2.80
Mechanism of action of quinolones against Escherichia coli DNA gyrase. Antimicrob Agents Chemother (1993) 2.48
Control of bacterial DNA supercoiling. Mol Microbiol (1992) 2.47
Cloning, sequencing, and expression of the DNA gyrase genes from Staphylococcus aureus. J Bacteriol (1993) 1.72
Biochemical characteristics and physiological significance of major DNA topoisomerases. Antimicrob Agents Chemother (1989) 1.55
gyrA mutations in ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus from Indiana, Minnesota, and Tennessee. J Infect Dis (1991) 1.54
Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches. J Antimicrob Chemother (1990) 1.37
Inhibitory effects of ciprofloxacin and sparfloxacin on DNA gyrase purified from fluoroquinolone-resistant strains of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1991) 1.32
Detection of novel mutations in the gyrA gene of Staphylococcus aureus by nonradioisotopic single-strand conformation polymorphism analysis and direct DNA sequencing. Antimicrob Agents Chemother (1994) 1.18
Dissociated resistance among fluoroquinolones. Antimicrob Agents Chemother (1994) 0.91
PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell (1999) 7.56
Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1992) 4.74
Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 3.98
Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2000) 3.78
Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2000) 2.67
Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J Biol Chem (1997) 2.35
Quantitative correlation between susceptibility and OprJ production in NfxB mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1996) 2.18
Optimal use of blood tests for assessment of thyroid function. JAMA (1993) 2.00
K+ currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts. Am J Physiol Heart Circ Physiol (2005) 1.89
High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob Agents Chemother (2000) 1.75
Molecular expression and pharmacological identification of a role for K(v)7 channels in murine vascular reactivity. Br J Pharmacol (2007) 1.75
A eukaryotic gene encoding an endonuclease that specifically repairs DNA damaged by ultraviolet light. EMBO J (1995) 1.63
Increase in susceptibility of Pseudomonas aeruginosa to carbapenem antibiotics in low-amino-acid media. Antimicrob Agents Chemother (1991) 1.61
Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study. Thyroid (1999) 1.58
Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid (1993) 1.49
Interplay between chromosomal beta-lactamase and the MexAB-OprM efflux system in intrinsic resistance to beta-lactams in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1999) 1.46
Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease. J Clin Invest (1997) 1.45
Involvement of transporter recruitment as well as gene expression in the substrate-induced adaptive regulation of amino acid transport system A. Biochim Biophys Acta (2001) 1.43
Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother (1996) 1.42
Relationship between transcardiac gradient of endothelin-1 and left ventricular remodelling in patients with first anterior myocardial infarction. Eur Heart J (2003) 1.41
Transapical aortic cannulation in pediatric patients. Ann Thorac Surg (1997) 1.40
New cephamycin antibiotic, CS-1170: binding affinity to penicillin-binding proteins and inhibition of peptidoglycan cross-linking reactions in Escherichia coli. Antimicrob Agents Chemother (1978) 1.37
Fate of untreated benign thyroid nodules: results of long-term follow-up. World J Surg (1995) 1.37
Mutation and haplotype analyses of the Werner's syndrome gene based on its genomic structure: genetic epidemiology in the Japanese population. Hum Genet (1997) 1.35
Local Ca(2+) transients and distribution of BK channels and ryanodine receptors in smooth muscle cells of guinea-pig vas deferens and urinary bladder. J Physiol (2001) 1.35
Abnormal telomere dynamics of B-lymphoblastoid cell strains from Werner's syndrome patients transformed by Epstein-Barr virus. Oncogene (1997) 1.34
Penicillin-binding proteins in Proteus species. J Bacteriol (1979) 1.26
Comparative in vitro activity of S-4661, a new parenteral carbapenem, and other antimicrobial agents against respiratory pathogens. Chemotherapy (2000) 1.25
Interferon gamma response region in the promoter of the human DPA gene. Proc Natl Acad Sci U S A (1990) 1.25
Analysis of helicase gene mutations in Japanese Werner's syndrome patients. Hum Genet (1997) 1.22
Myocardial stiffness derived from end-systolic wall stress and logarithm of reciprocal of wall thickness. Contractility index independent of ventricular size. Circulation (1990) 1.20
A unique human gene that spans over 230 kb in the human chromosome 8p11-12 and codes multiple family proteins sharing RNA-binding motifs. Proc Natl Acad Sci U S A (1996) 1.20
Sp1-mediated transcription of the Werner helicase gene is modulated by Rb and p53. Mol Cell Biol (1998) 1.19
Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1986) 1.18
Characterization of gyrA, gyrB, grlA and grlB mutations in fluoroquinolone-resistant clinical isolates of Staphylococcus aureus. J Antimicrob Chemother (1998) 1.17
Isolation and structure of dynorphin, an opioid peptide, from porcine duodenum. Nature (1982) 1.16
Primary structure, genomic organization, and functional and electrogenic characteristics of human system N 1, a Na+- and H+-coupled glutamine transporter. J Biol Chem (2000) 1.15
Primary structure, functional characteristics and tissue expression pattern of human ATA2, a subtype of amino acid transport system A. Biochim Biophys Acta (2000) 1.14
Activity of the carbapenem panipenem and role of the OprD (D2) protein in its diffusion through the Pseudomonas aeruginosa outer membrane. Antimicrob Agents Chemother (1993) 1.13
Evidence for the transport of neutral as well as cationic amino acids by ATA3, a novel and liver-specific subtype of amino acid transport system A. Biochim Biophys Acta (2001) 1.12
Down-regulation of the defective transcripts of the Werner's syndrome gene in the cells of patients. Biochem Biophys Res Commun (1997) 1.12
beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter. J Biol Chem (2000) 1.11
Cloning and functional characterization of a new subtype of the amino acid transport system N. Am J Physiol Cell Physiol (2001) 1.10
CDC45 and DPB11 are required for processive DNA replication and resistance to DNA topoisomerase I-mediated DNA damage. Proc Natl Acad Sci U S A (1999) 1.10
Identification and expression of the Neurospora crassa mei-3 gene which encodes a protein homologous to Rad51 of Saccharomyces cerevisiae. Mol Gen Genet (1995) 1.09
An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP. J Exp Med (1991) 1.06
Structure, function, and tissue expression pattern of human SN2, a subtype of the amino acid transport system N. Biochem Biophys Res Commun (2001) 1.05
Measurement of turbulence intensity in the center of the canine ascending aorta with a hot-film anemometer. J Biomech Eng (1983) 1.05
Cloning and functional expression of ATA1, a subtype of amino acid transporter A, from human placenta. Biochem Biophys Res Commun (2000) 1.04
[Management of mycobacteriosis in general hospital without isolation ward for tuberculosis patients. Clinical study on pulmonary tuberculosis associated with lung cancer patients]. Kekkaku (1999) 1.04
Thyrotoxicosis after needle aspiration of thyroid cyst. J Clin Endocrinol Metab (1992) 1.04
Calcification capacity of dental papilla mesenchymal cells transplanted in the isogenic mouse spleen. Anat Rec (1990) 1.03
The relationship between early diabetic nephropathy and control of plasma glucose in non-insulin-dependent diabetes mellitus. The effect of glycemic control on the development and progression of diabetic nephropathy in an 8-year follow-up study. J Diabetes Complications (1994) 1.03
Immunodetection of rice dwarf phytoreoviral proteins in both insect and plant hosts. Virology (1994) 1.03
C-type natriuretic peptide activates a non-selective cation current in acutely isolated rat cardiac fibroblasts via natriuretic peptide C receptor-mediated signalling. J Physiol (2007) 1.03
Synthesis and degradation of 1-aminocyclopropane-1-carboxylic acid by Penicillium citrinum. Biosci Biotechnol Biochem (1999) 1.02
Polycistronic (tri- or bicistronic) phytoreoviral segments translatable in both plant and insect cells. J Virol (1996) 1.02
cDNA structure, genomic organization, and promoter analysis of the mouse intestinal peptide transporter PEPT1. Biochim Biophys Acta (2000) 1.01
Loss of functional K+ channels encoded by ether-à-go-go-related genes in mouse myometrium prior to labour onset. J Physiol (2009) 1.01
Cloning of a mouse homologue of the human Werner syndrome gene and assignment to 8A4 by fluorescence in situ hybridization. Genomics (1997) 1.00
Inhibition of cholera toxin by human milk fractions and sialyllactose. Biosci Biotechnol Biochem (1995) 0.99
Thyroid cancer detected by ultrasound-guided fine-needle aspiration biopsy. World J Surg (1996) 0.99
A Neurospora double-strand-break repair gene, mus-11, encodes a RAD52 homologue and is inducible by mutagens. Mol Gen Genet (2000) 0.99
Phenotypic discordance in monozygotic twins with 22q11.2 deletion. Am J Med Genet (1998) 0.99
Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones. Antimicrob Agents Chemother (1999) 0.99
Accurate and simple method of diagnosing thyroid nodules the modified technique of ultrasound-guided fine needle aspiration biopsy. Thyroid (1995) 0.98
Nature of magnetic coupling between Mn ions in As-grown Ga1-xMnxAs studied by X-ray magnetic circular dichroism. Phys Rev Lett (2008) 0.97
Genistein augments cyclic adenosine 3'5'-monophosphate(cAMP) accumulation and insulin release in MIN6 cells. Endocr Res (1993) 0.97
Outcome of long standing solitary thyroid nodules. World J Surg (1992) 0.97
Immortalization of immunologically committed Epstein-Barr virus-transformed human B-lymphoblastoid cell lines accompanied by a strong telomerase activity. Differentiation (1997) 0.97
Closure of isolated ventricular septal defect with detachment of the tricuspid valve. J Card Surg (1995) 0.96
In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem. Antimicrob Agents Chemother (1997) 0.96
Gene expression profiling of Escherichia coli in response to interactions with the lettuce rhizosphere. J Appl Microbiol (2012) 0.95
Isolation and characterization of MMS-sensitive mutants of Neurospora crassa. Mutat Res (1984) 0.94
Characterization of the Neurospora crassa mus-25 mutant: the gene encodes a protein which is homologous to the Saccharomyces cerevisiae Rad54 protein. Mol Gen Genet (2000) 0.94
Ion-channel sensors. Anal Chem (1987) 0.93
Unintentional thyrotoxicosis factitia due to a diet pill. West J Med (1986) 0.93
Cowden's disease: familial goiter and skin hamartomas. A report of three cases. West J Med (1983) 0.92
A new approach to defining regional work of the ventricle and evaluating regional cardiac function: mean wall stress-natural logarithm of reciprocal of wall thickness relationship. Heart Vessels (1986) 0.92
Hypersusceptibility of the Pseudomonas aeruginosa nfxB mutant to beta-lactams due to reduced expression of the ampC beta-lactamase. Antimicrob Agents Chemother (2001) 0.92
Psychosocial study of depression in early pregnancy. Br J Psychiatry (1996) 0.92
Capability of complement fixation of pemphigus antibodies in vitro. Arch Dermatol Res (1977) 0.92
Validity of the Japanese version of the GHQ among antenatal clinic attendants. Psychol Med (1989) 0.91
High-resolution structure of the conger eel galectin, congerin I, in lactose-liganded and ligand-free forms: emergence of a new structure class by accelerated evolution. Structure (1999) 0.91
Computed tomographic features of uterine myoma. J Comput Assist Tomogr (1981) 0.91
Ca2+ spark as a regulator of ion channel activity. Jpn J Pharmacol (1999) 0.91
Purification and some properties of beta-lactamases from Proteus rettgeri and Proteus inconstans. Microbiol Immunol (1980) 0.91
Accessory nerve injury: conservative or surgical treatment? J Hand Surg Br (1991) 0.91
Apamin-sensitive Ca2+-dependent K+ current and hyperpolarization in human endothelial cells. Biochem Biophys Res Commun (1997) 0.90
Arterial wave intensity and ventriculoarterial interaction. Heart Vessels (1997) 0.90
Examination of antithyroid effects of smoking products in cultured thyroid follicles: only thiocyanate is a potent antithyroid agent. Acta Endocrinol (Copenh) (1992) 0.90
Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C. Am J Gastroenterol (1997) 0.90
Cloning and characterization of a human DEAH-box RNA helicase, a functional homolog of fission yeast Cdc28/Prp8. Nucleic Acids Res (1998) 0.90
Drug-induced hyponatraemia in psychogenic polydipsia. Postgrad Med J (1976) 0.90